A list of the Neuroscience Program faculty, with their contact information and a brief description of their research interests, is provided below. More details of faculty research and current laboratory rotation opportunities and projects can be found at the Graduate School faculty directory website.
| Name | Contact | Location | Research |
| Srdjan D. Antic, M.D. | antic@uchc.edu
860-679-8468 |
Main Building
E3052 |
Dendritic integration of synaptic inputs; dopaminergic modulation of dendritic excitability. |
| Byoung-Il Bae, Ph.D. | bbae@uchc.edu
860-679-8955 |
Main Building
L4075 |
We aim to understand the molecular and cellular mechanisms underlying human cerebral cortical development. |
| Rashmi Bansal, Ph.D. | bansal@uchc.edu
860-679-1133 |
Main Building
E4014 |
Developmental, cellular and molecular biology of oligodendrocytes; growth factor regulation of function and its relationship to neurodegenerative disease, including multiple sclerosis. |
| Leslie R. Bernstein, Ph.D. | les@uchc.edu
860-679-4622 |
Main Building
L3047 |
Behavioral neuroscience; psychoacoustics, binaural hearing. |
| Stormy J. Chamberlain, Ph.D. | chamberlain@uchc.edu
860-679-8351 |
400 Farmington
1236 |
Uses induced pluripotent stem cells (iPSCs) to study the human neurogenetic disorders, Angelman syndrome and 15q duplication syndrome. |
| Bojun Chen, PhD. | bochen@uchc.edu | Main Building
L4021 |
Molecular mechanism of neurotransmitter release regulation, and molecular mechanisms of gap junction function, assembly and regulation using C. elegans as a model system. |
| Jonathan M. Covault, M.D., Ph.D. | jocovault@uchc.edu
860-679-7560 |
Main Building
L4091 |
Genetic correlates of alcohol use disorders; role of neuroactive steroids in the effects of alcohol. |
| Stephen J. Crocker, Ph.D. | crocker@uchc.edu
860-679-8750 |
Main Building
E4054 |
Brain injury/repair; neurodegenerative diseases; neuroinflammation; myelin injury; neural stem cell differentiation; signal transduction; glia; matrix metalloproteinases/inhibitors. |
| Rosaria Guzzo, PhD | guzzo@uchc.edu
860-679-3026 |
Main Building
E4032 |
Epigenetic mechanisms underlying pluripotent stem cell differentiation, musculoskeletal development, and tissue homeostasis. |
| George A. Kuchel, MD, FRCP, AGSF | kuchel@uchc.edu
860-679-6796 |
ASB 2 | Aging; neural regulation of bladder function; resilience and neural plasticity. |
| Eric S. Levine, Ph.D. | eslevine@uchc.edu
860-679-2145 |
Main Building
E3053 |
Synaptic plasticity; role of endogenous cannabinoids and nerve growth factors in the hippocampus and cerebral cortex. |
| Yuanhao “James” Li, Ph.D. | jali@uchc.edu
860-679-3836 |
Main Building
E3014 |
Development of the central nervous system; cellular and molecular mechanisms underlying formation of the mammalian cerebellum |
| Leslie M. Loew, Ph.D. | les@uchc.edu
860-679-3568 |
400 Farmington
1608 |
Morphological determinants of cell physiology; image-based computational models; spatial variations of cell membrane electrophysiology; new optical methods for probing living cells. |
| Xin-Ming Ma, Ph.D. | ma@uchc.edu
860-679-7957 |
Main Building
E4030 |
Uses Induced pluripotent stem cell (iPSC)-derived neurons are using to study the mechanisms of the human psychiatric disorders, schizophrenia and cocaine addiction. Synaptogenesis and the plasticity of dendritic spines. |
| David Martinelli, PhD. | davidmartinelli@uchc.edu
860-679-2271 |
Main Building
L4003 |
Genetics, cell biology, biochemistry, and behavioral neuroscience in synaptic adhesion proteins and their role in neuropsychiatric disease. |
| Royce Mohan, Ph.D. | mohan@uchc.edu
860-679-2020 |
Main Building
L4023 |
Developing treatments for conditions and diseases of the eye that involve angiogenesis, fibrosis and gliosis. Developed first pharmacological probe of type III intermediate filaments (IFs), demonstrating the effective targeting of vimentin and glial fibrillary acidic protein by the natural product withaferin A. |
| Douglas L. Oliver, Ph.D. | doliver@uchc.edu
860-679-2241 |
Main Building
L3042 |
Circuitry and parallel information processing in the auditory system; neurobiology of hearing, deafness, and tinnitus; role of neuronal cell types and intrinsic membrane properties in information processing; structure and function of CNS sensory systems. |
| Phillip P. Smith, MD. | ppsmith@uchc.edu
860-679-3438 |
S7607 | Research regarding lower urinary tract physiology and dysfunction, especially in the context of aging. |
| Feliks (Ephraim) Trakhtenberg, Ph.D. | trakhtenberg@uchc.edu
860-679-7819 |
Main Building
L4005 |
Neuroregeneration: Integrating molecular, genetic, bioinformatic, and translational approaches in studying neuronal development, towards engineering gene therapy and nanotechnology-based therapeutics for regenerating injured nerve/brain tissues and connections. |
| Rajkumar Verma, PhD | verma@uchc.edu
860-679-4552 |
Main Building
E5050 |
Stroke research, Drug target validation, behavioral pharmacology and neuroimmune interaction. |
| Zhao-Wen Wang, Ph.D. | zwwang@uchc.edu
860-679-7659 |
Main Building
L4017 |
Molecular mechanism of neurotransmitter release regulation, and molecular mechanisms of gap junction function, assembly and regulation using C. elegans as a model system. |
| Ming Xu, PhD | mixu@uchc.edu
860-679-4338 |
EM013 | Discover novel interventions to slow down the aging process, and thereby alleviate a number of diseases simultaneously. |
| Riqiang Yan, Ph.D. | riyan@uchc.edu
860-679-3527 |
L4040C | Focuses on the study of how Alzheimer’s disease patients develop the pathologies in their brains and explores therapeutic treatment for this most common neurodegenerative disease. |
| Ji Yu, Ph.D. | jyu@uchc.edu
860-679-7680 |
400 Farmington
1605 |
Optical imaging technology; regulatory mechanisms in dendritic RNA translation; cytoskeletal dynamics. |
| Lixia Yue, Ph.D. | lyue@uchc.edu
860-679-3069 |
Main Building
EG024 |
Calcium signaling mechanism and its physiological/pathological functions in various systems. |